查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363298

子宮頸癌診斷市場規模、佔有率、趨勢分析報告：按測試類型、年齡層、最終用途、地區和細分市場預測，2023-2030年

Cervical Cancer Diagnostic Market Size, Share & Trends Analysis Report By Test Type (Pap Testing Or Cytology Testing, HPV Testing, Colposcopy, Cervical Biopsies), By Age Group, By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

子宮頸癌診斷市場的成長與趨勢：

Grand View Research, Inc.最新研究顯示，預計2023年至2030年全球子宮頸癌診斷市場規模將以5.7%的年複合成長率成長，2030年將達到70億美元。

主要促進因素包括子宮頸癌患病上升、篩檢技術的進步以及促進常規檢查和篩檢的各種計劃。根據世界衛生組織公佈的資料，2012年有超過27萬名女性死於子宮頸癌，其中大多數發生在開發中國家。子宮頸癌是女性最常診斷出的癌症之一。子宮頸癌是女性最常見的癌症之一，其原因包括生活方式的改變，例如多個性伴侶、飲酒和吸煙以及壓力增加。

此外，越來越多的積極主動的政府配合措施和意識計劃預計將在未來年度推動市場成長。美國國家子宮頸癌聯盟、世界衛生組織、疾病預防控制中心和美國預防服務工作小組努力促進中年女性進行早期子宮頸癌篩檢的必要性。

對技術先進的診斷程序的需求不斷增加，促進疾病的早期療育。產業公司致力於開發創新技術解決方案，以實現準確、高效的結果。篩選技術的進步，例如生物標記的使用，變得越來越重要。技術發展的激增預計將進一步推動行業成長。

由於巴氏試驗的日益普及，近年來子宮頸癌的死亡人數顯著下降。子宮頸抹片檢查有助於及早發現癌前病變，減少子宮頸癌病例的數量。美國癌症協會指出，過去40年度來，美國子宮頸癌病例數減少了50%以上。最初，每年進行巴氏試驗篩檢，導致不必要的程序。然而，美國癌症協會現在建議 21 至 29 歲之間的女性每三年進行一次巴氏檢查。

子宮頸癌診斷市場報告亮點：

  • 2022年，巴氏檢查部門佔了大部分市場佔有率，佔33.06%。該細分市場的大部分佔有率歸因於早期診斷測試的高效率。人們對早期診斷影響的認知不斷提高也促進了該領域的發展。
  • 2022年，北美以45.74%的收益佔有率引領區域市場。美國是北美的主要市場。子宮頸癌罹患率的增加以及政府機構以與早期篩檢相關的意識提升計劃的形式採取的配合措施是該國巨大市場佔有率背後的主要要素。
  • 預計亞太地區將呈現良好的成長勢頭，預測期內年複合成長率為 8.6%。印度、中國和菲律賓等開發中國家政府採取各種措施改善衛生基礎設施，增加獲得衛生設施的機會，這是該地區經濟快速成長的一個主要要素。開發中國家癌症的高患病和意識層級的提高也推動了成長。
  • 該市場目前由 Becton、Dickinson and Company、F. Hoffmann-La Roche Ltd、Abbott Laboratories、OncoHealth Corp、Hologic, Inc.、QIAGEN、Quest Diagnostics, Inc. 和 Guided Therapeutics, Inc. 等主要參與企業主導。領先的公司特別致力於開發創新的診斷解決方案。例如，2014年，F. Hoffmann-La Roche Ltd.推出了自動化CINtec PLUS細胞學檢測，可有效檢測癌前細胞的存在。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 子宮頸癌診斷市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 子宮頸癌診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章 子宮頸癌診斷市場：按測試類型的估計和趨勢分析

  • 子宮頸癌診斷市場，按測試類型分類的要點
  • 子宮頸癌診斷市場：2022年和2030年趨勢和市場佔有率分析
  • 巴氏抹片檢查
  • HPV檢測
  • 陰道鏡檢查
  • 子宮頸切片檢查
  • 膀胱鏡檢查

第5章 子宮頸癌診斷市場：依年齡層別估算及趨勢分析

  • 子宮頸癌診斷市場，依年齡層別分類的要點
  • 子宮頸癌診斷市場：2022年和2030年趨勢和市場佔有率分析
  • 20-40歲
  • 40歲以上

第6章 子宮頸癌診斷市場：最終用途的估計和趨勢分析

  • 子宮頸癌診斷市場，依最終用途分類的要點
  • 子宮頸癌診斷市場：2022年和2030年趨勢和市場佔有率分析
  • 醫院
  • 實驗室
  • 診斷中心

第7章 子宮頸癌診斷市場：區域估計及趨勢分析

  • 區域展望
  • 依地區分類的子宮頸癌診斷市場：市場要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Abbott Laboratories
    • Ouigan NV
    • Thermo Fisher Scientific Inc
    • Dickinson and Company
    • Hologic Inc
    • CooperSurgical Inc
    • Siemens Healthineers
Product Code: GVR-1-68038-127-6

Cervical Cancer Diagnostic Market Growth & Trends:

The global cervical cancer diagnostic market size is expected to reach USD 7.0 billion by 2030, growing at a CAGR of 5.7% from 2023 to 2030, according to a new study conducted by Grand View Research, Inc.. The key driving factors include the rising prevalence of cervical cancer, evolving screening technology, and various programs that promote routine check up and screening. According to the data published by the WHO, in 2012, over 270,000 women died due to cervical cancer, majority of which were from the developing countries. It is one of the most common cancer type diagnosed in women. Some of the etiological factors are multiple sex partners, and changing lifestyle, such as drinking & smoking and increased stress levels.

Furthermore, favorable government initiatives and increasing number of awareness programs are further expected to promote the market growth in coming few years. The National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, are working towards promoting the necessity for early screening of cervical cancer amongst mid aged women.

There is an increasing demand for technologically advanced diagnostic procedures that facilitate the early intervention of the disease. The industry players are focused on developing innovative technological solutions for accurate and efficient results. Advancement in screening techniques, such as use of biomarkers, is gaining importance. The upsurge in technological developments is anticipated to further drive industry growth.

On account of increasing adoption of Pap test, the number of deaths due to cervical cancer has declined significantly in past few years. It helps detect precancerous lesions at an early state and, thus, reduces the number of cervical cancer cases. The American Cancer Society stated that the cervical cancer cases in last 40 years in the U.S. have declined by more than 50%. Initially, the Pap test screening was carried out every year which lead to further unnecessary procedures. However, the American Cancer Society now recommends that women in the age group of 21 to 29 should undergo Pap test every 3 years.

Cervical Cancer Diagnostic Market Report Highlights:

  • In 2022, the Pap testing segment held majority of the market share of 33.06%. The segment's large share can be attributed to the high efficiency of the tests in early diagnosis. Also, the increasing awareness about the impact of early diagnosis contributed to its growth.
  • In 2022, North America was the leading regional market with a revenue share of 45.74%. The U.S. is a key market in North America. Growing incidence of cervical cancer coupled with initiatives undertaken by government agencies in the form of awareness programs pertaining to the early screening of the disease are key factors for the country's large market share.
  • Asia Pacific is expected to witness lucrative growth over the forecast period growing at a CAGR of 8.6%. The various steps undertaken by governments of developing countries such as India, China, Philippines, and other in order to improve healthcare infrastructure and to improve access to healthcare facilities are amongst key factors attributing to region's high growth. Also, high prevalence of cancer in developing nations and increasing consumer awareness levels drive the growth
  • This market is presently dominated by a few key participants such as Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics, Inc and Guided Therapeutics, Inc. The key players focus specially on developing innovative solutions for diagnosis. For instance, F. Hoffmann-La Roche Ltd., in 2014, launched automated CINtec PLUS cytology test that efficiently detects the presence of precancerous cells.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Age group
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Age group outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cervical Cancer Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. The increasing demand for cervical cancer screening tools
      • 3.4.1.2. Increase in cervical cancer cases across the globe
      • 3.4.1.3. Technological advancements
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited number of approved products
      • 3.4.2.2. Complications/risks associated with microneedles
  • 3.5. Cervical Cancer Diagnostic Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Cervical Cancer Diagnostic Market: Test Type Estimates & Trend Analysis

  • 4.1. Cervical Cancer Diagnostic Market, By Test Type Key Takeaways
  • 4.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pap Testing
    • 4.3.1. Pap testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. HPV Testing
    • 4.4.1. HPV testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Colposcopy
    • 4.5.1. Colposcopy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cervical Biopsies
    • 4.6.1. Cervical biopsies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cystoscopy
    • 4.7.1. Cystoscopy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cervical Cancer Diagnostic market: Age group Estimates & Trend Analysis

  • 5.1. Cervical Cancer Diagnostic Market, By Age group Key Takeaways
  • 5.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. 20-40 years
    • 5.3.1. 20-40 years market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Above 40 years
    • 5.4.1. Above 40 years market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cervical Cancer Diagnostic market: End Use Estimates & Trend Analysis

  • 6.1. Cervical Cancer Diagnostic Market, By End Use Key Takeaways
  • 6.2. Cervical Cancer Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Laboratories
    • 6.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cervical Cancer Diagnostic Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Cervical Cancer Diagnostic Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Ouigan NV
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Thermo Fisher Scientific Inc
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Dickinson and Company
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Hologic Inc
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. CooperSurgical Inc
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Siemens Healthineers
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 4 North America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 8 U.S. cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 11 Canada cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Europe cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 14 Europe cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 18 Germany cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 21 UK cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 24 France cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 27 Italy cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 30 Spain cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Sweden cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Sweden cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 33 Sweden cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Norway cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Norway cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 36 Norway cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Denmark cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Denmark cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 39 Denmark cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 45 China cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 46 China cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 49 Japan cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 52 India cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Thailand cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Thailand cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 55 Thailand cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 57 South Korea cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 58 South Korea cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Latin America cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 60 Latin America cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 61 Latin America cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 64 Brazil cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 65 Brazil cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Mexico cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Mexico cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 68 Mexico cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Argentina cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Argentina cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 71 Argentina cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cervical cancer diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 77 South Africa cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 78 South Africa cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 82 UAE cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 83 UAE cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 84 UAE cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait cervical cancer diagnostic market, by test type, 2018 - 2030 (USD Million)
  • Table 86 Kuwait cervical cancer diagnostic market, by age group, 2018 - 2030 (USD Million)
  • Table 87 Kuwait cervical cancer diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cervical cancer diagnostic: Market outlook
  • Fig. 9 Cervical cancer diagnostic: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cervical cancer diagnostic market driver impact
  • Fig. 15 Cervical cancer diagnostic market restraint impact
  • Fig. 16 Cervical cancer diagnostic market strategic initiatives analysis
  • Fig. 17 Cervical cancer diagnostic market: Test Type movement analysis
  • Fig. 18 Cervical cancer diagnostic market: type outlook and key takeaways
  • Fig. 19 Pap testing market estimates and forecasts, 2018 - 2030
  • Fig. 20 HPV testing market estimates and forecasts, 2018 - 2030
  • Fig. 21 Colposcopy market estimates and forecasts, 2018 - 2030
  • Fig. 22 Cervical biopsies market estimates and forecasts, 2018 - 2030
  • Fig. 23 Cytoscopy market estimates and forecasts, 2018 - 2030
  • Fig. 24 Cervical cancer diagnostic market: Age-group movement analysis
  • Fig. 25 Cervical cancer diagnostic market: age-group outlook and key takeaways
  • Fig. 26 20-40 years market estimates and forecasts, 2018 - 2030
  • Fig. 27 Above 40 years market estimates and forecasts, 2018 - 2030
  • Fig. 28 Cervical cancer diagnostic market: End use movement analysis
  • Fig. 29 Cervical cancer diagnostic market: end use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Diagnostic centers management market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global Cervical cancer diagnostic market: Regional movement analysis
  • Fig. 34 Global Cervical cancer diagnostic market: regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 41 France market estimates and forecasts, 2018 - 2030
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 China market estimates and forecasts, 2018 - 2030
  • Fig. 50 India market estimates and forecasts, 2018 - 2030
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030